M. Mahdy

Temozolomide and radiotherapy in newly diagnosed glioblastoma patients: O6-methylguanine-DNA methyltransferase (MGMT) promotor methylation status and Ki-67 as biomarkers for survival and response to treatment

M. A. Abdel Wahab, K. A. Abdel Karim, M. M. Mahdy, 2012 .

BRCA1 and EGFR as prognostic biomarkers in triple negative metastatic breast cancer patients treated with cisplatin plus docetaxel

L. E. Elarab, K. Karim, M. M. Mahdy, 2010 .